TFC Financial Management’s 10x Genomics TXG Stock Holding History

TFC Financial Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Hold	57	–	–	﹤0.01%	563
2026 Q1	$1.21K	Hold	57	–	–	﹤0.01%	593
2025 Q4	$930	Buy	57 +1	+2%	+$15	﹤0.01%	605
2025 Q3	$655	Hold	56	–	–	﹤0.01%	676
2025 Q2	$649	Buy	+56	New	+$510	﹤0.01%	639
2023 Q3	–	Sell	-6	Closed	-$336	–	702
2023 Q2	$336	Buy	+6	New	+$325	﹤0.01%	632

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TFC Financial Management's TXG Position: Q2 2026 in Review

TFC Financial Management held its 10x Genomics (TXG) position steady in Q2 2026 at 57 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #563.

TFC Financial Management first reported a position in TXG in Q2 2023 and has held it in 6 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

TFC Financial Management held 57 shares of 10x Genomics worth $2.19K as of Q2 2026.
TFC Financial Management left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #563 holding.
TFC Financial Management first reported a position in 10x Genomics in Q2 2023 and has held it in 6 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.